Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older

S. Vañó-Galván, I. Figueras-Nart, C. Serrano, M.P. Fortes, V. Herrera-Lasso, R. Botella-Estrada

Open source

DOI
10.1016/j.ad.2025.104487
Published
2026-01
Container
Actas Dermo-Sifiliográficas
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ad.2025.104487,
  title = {Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older},
  author = {S. Vañó-Galván and I. Figueras-Nart and C. Serrano and M.P. Fortes and V. Herrera-Lasso and R. Botella-Estrada},
  year = {2026},
  journal = {Actas Dermo-Sifiliográficas},
  doi = {10.1016/j.ad.2025.104487},
  url = {https://doi.org/10.1016/j.ad.2025.104487}
}

RIS

TY  - JOUR
TI  - Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
AU  - S. Vañó-Galván
AU  - I. Figueras-Nart
AU  - C. Serrano
AU  - M.P. Fortes
AU  - V. Herrera-Lasso
AU  - R. Botella-Estrada
PY  - 2026
JO  - Actas Dermo-Sifiliográficas
DO  - 10.1016/j.ad.2025.104487
UR  - https://doi.org/10.1016/j.ad.2025.104487
ER  - 

APA

Vañó-Galván, S., Figueras-Nart, I., Serrano, C., Fortes, M., Herrera-Lasso, V., & Botella-Estrada, R. (2026). Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2025.104487

Source records